他克莫司对癫痫持续状态大鼠海马PKCδ表达的影响
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
背景及目的:癫痫(Epilepsy, EP)是大脑神经元过度同步异常放电导致的神经系统功能异常综合征。癫痫持续状态(Status Epilepticus, SE)是癫痫连续发作之间意识未完全恢复又频繁再发,或发作持续30分钟以上不自行停止,可导致急性或持续性的认知及行为改变,是神经内科常见急症之一。
     蛋白激酶C(Protein kinase C, PKC)参与神经元的生长、分化和凋亡等生理病理过程。PKCδ是一种新型的PKC亚型的成员,在各种刺激因素的作用下,PKCδ可促使caspase3活化,引起细胞凋亡。钙调神经磷酸酶(Calcineurin,CaN)为丝/苏氨酸蛋白磷酸酶家族成员,我们既往研究结果表明,CaN可引起难治性癫痫,他克莫司(Tacrolimus, FK506)可通过特异性抑制CaN控制癫痫发生,逆转神经元损伤。已有研究发现,在脑缺血模型中,CaN活化后激活PKC,引起细胞内信号传导。在癫痫的病理生理过程中,关于PKC各亚型与CaN的相互作用,以及对于神经元损伤的影响,尚缺乏相关研究。
     本研究应用Wistar大鼠建立氯化锂-匹鲁卡品癫痫持续状态模型,观察海马形态学变化、PKCδ的表达及FK506对其的影响,探究CaN与依赖PKCδ的细胞凋亡途径之间的关系。
     方法:
     1.动物模型:将108只健康成年雄性大鼠随机分为对照组(Control组)、癫痫组(SE组)和FK506处理组(FK506组),每组36只。SE组与FK506组各分为6组,分别于SE后3、6、12、24、72h及7d处死取材,对照组大鼠不建立癫痫模型,于对应时间点处死。
     2.行为学观察:根据Racine分级观察大鼠癫痫发作行为变化,记录癫痫发作潜伏期及发作程度。
     3.脑组织病理学观察:HE染色观察SE后7d海马区神经元的损伤。
     4. RT-PCR法:检测SE后不同时点(3、6、12、24、72h)海马PKCδmRNA的表达。
     5.免疫组织化学SP法:检测SE后不同时点(3、6、12、24、72h)海马PKCδ蛋白的表达。
     结果:
     1.FK506抑制癫痫发作:SE组和FK506组大鼠在注射匹鲁卡品后均出现癫痫发作,开始发作程度较轻,逐渐加重,直至出现癫痫持续状态。两组发作潜伏期和发作程度不同。与SE组相比,FK506组大鼠潜伏期明显延长(P<0.01),发作级别降低(P<0.05):Control组大鼠无痫性发作。
     2.FK506减轻SE后海马神经元损伤:在光镜下,SE后7dControl组大鼠海马CA3区神经元排列整齐,形态正常,无神经元缺失;SE组大鼠海马CA3区神经元排列紊乱,失去正常结构,与对照组相比神经元缺失严重(P<0.05);FK506组大鼠海马CA3区神经元数目较对照组减少,但较SE组存活神经元明显增多(P<0.05)。
     3.FK506抑制PKC8的表达:Control组PKC8mRNA和蛋白仅有少量表达;与Control组相比,SE组各个时点PKC8表达均显著增多(P<0.05),SE后6h PKC8mRNA表达最高,PKC8蛋白的平均光密度值SE后12h达高峰(P<0.01),以后二者均逐渐降低,但72h仍高于对照组水平(P<0.05);FK506组降低其表达,同时可减轻海马神经元损伤(P<0.05)。
     结论:
     FK506可能通过特异性抑制CaN间接调节依赖PKC8的细胞凋亡途径,减少SE后神经元损伤,发挥抗癫痫和脑保护作用,为临床应用免疫抑制剂治疗癫痫提供新的理论依据。
Backgroud and Objective:Epilepsy (EP) is a nervous system dysfunction syndrome,which is due to cerebral neurons excessive synchronous abnormal discharge. Status epilepticus (SE) refers to frequent clinical seizures without complete recovery of consciousness or the occurrence of a single unremitting seizure lasting more than30minutes to stop on its own,which can lead to acute or persistent changes of cognition and behavior and is a medical emergency of department of neurology.
     Protein kinase C (PKC) participates in physiological and pathological processes,such as the growth、differentiation and apoptosis of neurons. PKCδ,a member of a new kind of PKC isoforms,can activate caspase3under the effects of various stimulus,resulting in apoptosis. Calcineurin (CaN) is a member of serine/threonine protein phosphatase families. Our previous research shows that CaN can cause refractory epilepsy,and tacrolimus (FK506,a specific inhibition of CaN) is able to control epilepsy development、reverse neuronal injury. It has been found that in the model of cerebral ischemia,CaN can activate PKC,causing intracellular signal transduction. In the pathophysiological process of epilepsy,the interaction between PKC and CaN and neuronal damage is still short of related research.
     Our this study,we use Wistar rats to build lithium chloride-pilocarpine-induced status epilepticus model to observe the morphologic changes of the hippocampus, the expression of protein kinase Cδ and the influence of FK506on it,and explore the relationship between CaN and PKCδ-dependent apoptotic pathway.
     Methods:
     1. Animal models:One hundred and eight healthy adult male Wistar rats were randomly divided into the control group,the epilepsy group and the FK506group (36rats in each group). SE group and FK506group were divided into six groups, espectively3,6,12,24,72hours and7days after SE were sacrificed. At the same time, control group rats without being established epilepsy model, were sacrificed at corresponding time points.
     2. Behavioral observation:Observe the epileptic seizure of rats on the basis of Racine classification, and record seizures incubation period and the onset level.
     3. Observation of brain tissue pathology:Observe the hippocampal neuronal damage7days after SE by HE staining.
     4. RT-PCR:Detect the expression of PKCδ mRNA in the hippocampus at different time points (3,6,12,24,72h) after SE.
     5. Immunohistochemistry(SP):Detect the expression of PKCδprotein in the hippocampus at different time points (3,6,12,24,72h) after SE.
     Results:
     1. FK506inhibited seizures:After injection of pilocarpine,the SE group and the FK506rats had seizures,the onset at a lesser extent and gradually increased until the status epilepticus. Incubation period and the onset level of the two groups were different. Compared with the SE group,incubation period of the FK506group was significantly longer (P<0.01), and the onset level lower (P<0.05). The control group did not have seizures.
     2. FK506reduced SE hippocampal neurons injuries:Under the light microscope, the control group neurons arranged in neat rows, had normal morphology and had no neuronal loss in the hippocampal CA3region of rats7days after SE. In the SE group, the neurons arranged in disorder and lost normal structure; compared with the control group,the neurons lost more (P<0.05). Compared with the control group,the neurons number of the FK506group decreased,but compared with the SE group,survival neurons increased significantly (P<0.05).
     3. FK506suppressed the expression of PKC8:There were a few expressions of PKCδ mRNA and protein in the control group. Compared with the control group, the expressions of PKC8in the epilepsy group were increased observably (P<0.05),the expression of PKCδ mRNA arrived at a peak6h after SE,the expression of PKCδ protein arrived at a peak12h after SE(P<0.01), and both of PKCδ mRNA and protein were still more than the level of the control group72h after SE (P<0.05). Compared with the epilepsy group,pre-treatment with FK506could remarkably decrease the expression of PKCδ and also obviously alleviate hippocampal neuronal damage (P<0.05)
     Conclusions:
     FK506may regulate the PKCδ-dependent apoptotic pathway, reduce neuronal damage after SE and exert anti-epileptic and cerebral protection effects by inhibiting the CaN specifically,which provide a new drug target for the clinical application of immunosuppressive to treat epilepsy.
引文
[1]Scharfinan HE.The neurobiology of epilepsy. Curr Neurol Neurosci ReP,2007,7(4):348-354.
    [2]Wiedenmann B, Franke WW. Identification and localization of synaptophysin, an integral membrane glyeoProtein of Mr 38,000 characteristic of presynaptic vesieles[J]. Cell,1985,41(3):1017-1028.
    [3]Takai Y, Kishimoto A, Inoue M, et al. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I.Purification and characterization of an active enzyme from bovine cerebellum[J]. J Biol Chem,1977,252(21):7603-7609.
    [4]Sun MK, Hongpaisan J, Alkon DL. Postischemic PKC activation rescues retrograde and anterograde long-term memory. Proc Natl Acad Sci USA. 2009,106(34):14676-14680.
    [5]Bright R, Raval AP, Dembner J M, et al. Protein kinase C delta mediates cerebral reperfusion injury in vivo[J]. Neurosci,2004,24(31):6880-6888.
    [6]Katsura K I, Kurihara J, Kato H, et al. Ischemic preconditioning affects the subcellular distribution o f protein kinase C and calcium/calmodulin-dependent protein kinase II in the gerbil hippocampal CA1 neurons [J]. Neurol Res,2001, 23(7):751-754.
    [7]杨丽静,李凤玲.蛋白激酶C与脑血管病[J].国外医学脑血管疾病分册,2004,12(10):774-777.
    [8]Yoshida K, Miki Y, Kufe D. Activation of SAPK/JNK signaling by PKCδ in response to DNA damage[J]. J Biol Chem,2002,277(50):48372-48378.
    [9]Hopper R A, Forrest C R, Xu H, et al. Role and mechanism of PKC in ischemic preconditioning of pig skeletal muscle against infarction[J]. Am J Physiol Regul Integr Comp Physiol,2000,279(2):R666-676.
    [10]Murriel CL, Churchill E, Inagaki K, et al. Protein kinase C delta activation induces apoptosis in response to cardiac ischemia and reperfusion damage:a mechanism involving BAD and the mitochondria[J]. J Biol Chem,2004,279(46):47985-47991.
    [11]Humphries M J, Limesand K H, Schneider J C, et al. Suppression of apoptosis in the protein kinase Cdelta null mouse in vivo[J]. Biol Chem,2006,281(14):9728-9737.
    [12]Voss O H, Kim S, Wewers M D, et al. Regulation of monocyte apoptosis by the protein kinase Cdelta-dependent phosphorylation of caspase-3[J]. J Biol Chem, 2005,280(17):17371-17379.
    [13]Kamada S, Kikkawa U, Tsujimoto Y, et al. Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s)[J]. J Biol Chem,2005,280(2):857-860.
    [14]Kurz JE, Moore BJ, Henderson SC, et al. A cellular mechanism for dendritic spine loss in the pilocarpine model of status epilepticus[J]. Epilepsia,2008, 49(10):1696-1710.
    [15]Lakshmikuttyamma A, Selvakumar P, Charavaryamath C, et al. Expression of calcineurin and its interacting proteins in epileptic fowl[J]. J Neurochem,2006, 96(2):366-373.
    [16]Daoud D, Scheld HH, Speckmann EJ, et al. Rapamycin:brain excitability studied in vitro[J]. Epilepsia,2007,48(4):834-836.
    [17]Lin YW, Yang HW, Min MY, et al. Inhibition of associative long-term depression by activation of beta-adrenergic receptors in rat hippocampal CA1 synapses. J Biomed Sci,2008,15(1):123-131.
    [18]Xifro X, Garcia-Martinez JM, Del Toro D, et al. Calcineurin is involved in the early activation of NMD A-mediated cell death in mutant huntingtin knock-in striatal cells[J]. J Neurochem,2008,105(5):1596-1612.
    [19]Yi KD, Simpkins JW. Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection[J]. Endocrinology, 2008,149(10):5235-5243.
    [20]Sanchez RM, Dai W, Levada RE, et al. AMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brain[J]. J Neurosci,2005,25(13):3442-3451.
    [21]Vignes M. Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons[J]. Neuropharmacology,2001,40(6):737-748.
    [22]Lakshmikuttyamma A, Selvakumar P, Tuchek J, et al. Myristoyltransferase and calcineurin:novel molecular therapeutic target for epilepsy[J]. Prog Neurobiol,2008,84(1):77-84.
    [23]Kurz J E, Moore B J, Henderson S C, et al. A cellular mechanism for dendritic spine loss in the pilocarpine model of status epilepticus[J]. Epilepsia, 2008,49(10):1696-1710.
    [24]Lakshmikuttyamma A, Selvakumar P, Charavaryamath C, et al. Expression of calcineurin and its interacting proteins in epileptic fowl[J]. J Neurochem,2006, 96(2):366-373.
    [25]Kurz JE, Rana A, Parsons JT, et al. Status epilepticus induced changes in the subcellular distribution and activity of calcineurin in rat forebrain[J]. Neurobiol Dis,2003,14(3):483-493.
    [26]Aronowski J, Grotta J C, Strong R, et al. Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia[J]. J Cereb Blood Flow Metab,2000,20(2):343-349.
    [27]Endale M, Kim SD, Lee WM, et al. Ischemia induces regulator of G protein signaling 2 (RGS2) protein upregulation and enhances apoptosis in astrocytes[J]. Am J Physiol Cell Physiol.2010,298(3):C611-623.
    [28]Fung J,Abu-Elmagd K, Jain A, etal.A randomized Trial of primary liver transplantation under immunosuppression with FK506 vs cyclosporine.Transplant Proc,1991,23(6):2977-2983.
    [29]Klintmalm GB. FK506:an update.Clin transplant.1994,8(2Pt2):207-210.
    [30]Snyder SH, Lai MM, Burnett PE. Immunophilins in the nervous system[J]. Neuron.1998;21 (2):283-294.
    [31]Sharkey J,Butcher SP.Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia[J].Nature.1994,371(6495):336-339.
    [32]Snyder S, Sabatini D. Immunophilins and the nervous system[J]. Nature Med,1995,1(1):32-37.
    [33]Aihua Wanga, Zhaofu Chi, Shengjun Wang, et al. Calcineurin mediated GABAA receptor dephosphorylation in rats with kainic acid-induced status epilepticus[J]. Seizure,2009,18(7):519-23.
    [34]Jinzhi Liu, Aihua Wang, Lili Li, et al. Oxidative stress mediates hippocampal neuron death in rats after lithium-pilocarpine-induced status epilepticus[J]. Seizure,2010,19(3):165-172
    [35]Klitgaard H, Matagne A, Vanneste-Goemaere J, et al.Pilocarpine-induced epileotogenesis in the rat:impact of initial duration of status epilepticus on electrophysiological and neuropathlogical alterations[J]. Epilepsy Res,2002, 51:93-107.
    [36]Proper EA, Jansen GH, Veelen CW, et al. A grading system for hippocampal selerosis based on the degree of hippocampal mossy fiber sprouting[J]. Acta Neuropathol,2001,101:405-09.
    [37]Racine RJ. Modification of seizure activity by electrical stimulation. II.Motor seizure. Electroencephalogr Clin Neurophysiol.1972:32(3):281-294.
    [38]Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy:rewiring the brain[J]. Prog Neurobiol,2004,73(1):1-60.
    [39]Krsek P, Mikulecka A, Druga R, et al. An animal model of nonconvulsive status epilepticus:a contribution to clinical controversies[J]. Epilepsia,2001,42(2):171-180.
    [40]Chu K, Kim M, Jung KH, et al. Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats[J]. Brain Res,2004,1023(2):213-221.
    [41]梁益,孙红斌.氯化锂-匹罗卡品癫痫模型研究.实用医院临床杂志,2008,5(3):112-115.
    [42]Savolainen KM, Hirvonen MR. Second messengers in cholinergic induced convulsionsand neuronal injury.Toxicol Lett,1992,64:43-45.
    [43]Einet H, Kofman O, Itkin O, et al. Augmentation of lithium's behaviral effect by inositol uptake inhibitors[J]. J NeuralTransm,1998,105:31-38.
    [44]Willliams MB, Jope RS. Modulation by inositol of cholinergic-and serotonergic-induced seizures in lithium-treated rats. Brain Res,1995,685(1-2):169-178.
    [45]Sumanont Y, Murakami Y, Tohda M, et al. Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin.Life sci,2006,78(16):1884-1891.
    [46]Chuang YC, Chen SD, Liou CW, et al.Contribution of nitric oxide, superoxide anion, and peroxynitrite to activation of mitochondrial apoptotic signaling in hippocampal CA3 subfield following experimental temporal lobe status epilepticus[J]. Epilepsia,2009,50(4):731-746.
    [47]Proctor MR, Fornai F, Afshar JK, et al.The role of nitric oxide in focally-evoked limbic seizures. Neuroscience,1997,76(4):1231-1236.
    [48]Kaputlu I, Uzbay T. L-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice. Brain Res,1997,753(1):98-101.
    [49]Osonoe K, Mori N, Suzuki K, et al. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats.Brain Res, 1994,663(2):338-340.
    [50]Royes LF, Fighera MR, Furian AF, et al. Involvement of NO in the convulsive behavior and oxidative damage induced by the intrastriatal injection of methylmalonate. Neurosci Lett,2005,376(2):116-120.
    [51]Yamamoto, Shiosaka S, Whittaker ME, et al. Gap junction protein in rat hippocampus:light microscope immunohistochemical localization[J]. Com Neurol,1989:281 (2):269-81.
    [52]刘丽君,彭建新,洪华珠,等.线粒体在细胞凋亡中的变化与作用[J].细胞生物学杂质,2005,27:117-120.
    [53]Liou AK, Clark RS, Henshall DC, et al. To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy:a review on the stress aetivated signaling pathways and apoptotic pathways[J].Prog Neurobiol,2003,69(9):103-142.
    [54]Ferrer 1, Lopez E, Blanco R, et al. Differential c-Fos and caspase expression following kainic acid excitotoxicity[J]. Acta Neuropathol,2000,99(3):245-256.
    [55]Tan Z, Sankar R, Tu W, et al. Immunohistochemical study of p53-associated proteins in rat brain following lithium-pilocarpine status epilepticus[J]. Brain Res,2002,929(2):129-138.
    [56]Stewart VC, Heales SJ. Nitric oxide-induced mitochondrial dysfunction:implications for neurodegeneration. Free Radic Bio Med,2003,34(3):287-303.
    [57]Chuang YC, Alice YW, Lin CW, et al.Mitochondrial Dysfunction and Utrastructrual Damage in the Hippocampus during Kainic Acid-induced Status Epilepticus in the Rat[J]. Epilepsia,2004,45(10):1202-1209.
    [58]Henshall DC, Bonislawski DP, Skradski SL, et al. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death[J]. Cell Death Differ,2001,8(12):1169-1181.
    [59]Nishizaka Y. A case of systemic lupus erythematosus associated with sjogren's syndrome diagnosed by lung localization[J]. Science,1992,258:607-614.
    [60]Wieloch T, Cardell M, Bingren H, et al. Changes in the activity of protein kinase c and the differential subcellular redistribution of its isozymes in the rat striatum during and following transient forebrain ischemia[J]. Neurochem,1991, 56:1227-1235.
    [61]Wang Y, An R, Dong X, et al. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells. Urol Int 2009,82(2):214-221.
    [62]Brodie C,Blumberg PM. Regulation of cell apoptosis by Protein kinase c delta[J]. Apoptosis,2003,8(1):19-27.
    [63]Kajstura J,Cigola E,MALHOTRA a Malhotra A,et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol,1997,29(3):859-870.
    [64]Miguel BG, Fernandz 1, Toboso i, et al. Sphingosylphosphorylcholine induces mitochondria mediated apoptosis in neuron za cells:involvement of protein kinase C. Acta Neuronbiol Exp,2008,68(4):443-452.
    [65]Jun CD,Park SJ,Choi BM,et al. Potentiation of the activator phorbol ester in human myeloid leakemic HL-60 cells:association with enhanced fragmentation of mature genomic DNA.Cell Immunol,1997,176(1):41-49.
    [66]Endale M, Kim S D, Lee W M, et al. Ischemia induces regulator of G protein signaling 2 (RGS2) protein upregulation and enhances apoptosis in astrocytes[J]. Am J Physiol Cell Physiol,2010,298(3):C611-623.
    [67]Wang Y, Beck W, Deppisch R, et al. Differential effects of dialysis and ltrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization[J]. Am J Physiol Renal Physiol,2008, 294(1):F220-F228
    [68]Buschmann T, Adler V, Matusevich E, et al. p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase,p14ARF,and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation. Cancer Res,2000,60(4):896-900.
    [69]Chen L, Huang LY. Protein kinase C reduces Mg2+ block of NMDA-receptor channels as mechanism of modulation. Nature,1992,356(6369):521-523.
    [70]Pinton P, Giorgi C, Siviero R, et al. Calcium and apoptosis:ER-mitochondria Ca2+transfer in the control of apoptosis. Oncogene,2008,27(50):6404-6418.
    [71]GOLD BG. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration[J]. Drug Metab Rev,1999,31 (3):649663.
    [72]Goto T, Kino T, Hatanaka H, et al.Transplant Proc.1987,19(5 suppl 6):4-8.
    [73]郭应禄主编.肾移植进展[M].北京:北京医科大学出版社,2002,161-162.
    [74]Yang CW, Ahn HJ, Han HJ, et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney[J]. Transplantation,2001,72(11):1753-1759.
    [75]Steiner JP, Dawson TM, Fotuhi M, et al. High brain densities of the immunophilin FKBP colocalized with calneurin. Nature,1992,358(6387):584-587.
    [76]Benetoli A, Paganelli RA, Giordani F, et al. Effect of tacrolimus (FK506) on ischemia-induced brain damage and memory dysfunction in rats. Pharmacol Biochem Behav,2004,77(3):607-15.
    [77]Macleod MR, O'Collins T, Horky LL, et al. Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab,2005,25(6):713-21.
    [78]Gold BG, Villafranca JE. The development of novel neumregeneractive/neumpmtective compounds. Curt Top Med Chem,2003, 3:1368-1375.
    [79]Udina E, Rodriguez FJ, Verdu E, et al. FK506 enhances regeneration of axons across long peripheral nerve gaps repaired with collagen guides seeded with allogeneic Schwann cells.Glia,2004,47(2):120-9.
    [80]Furuichi Y,Katsuta K,Maeda M.Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents:dose dependency,therapeutic time window and long-term efficacy. Brain Research,2003,965:137-145.
    [81]Okajima S, Hojo T, Tamai K, et al. Histological and electrophysiological analysis of the peripheral nerve allografts using an immunosuppressive agent. Microsc Res Tech,2002,58(1):52-8.
    [82]Setkowicz Z,Ciarach M.Neuroprotectants FK-506 and cyclosporine A ameliorate the course of pilocarpine-induced seizures. Epilepsy Res,2007;73(2):151-155.
    [83]Asai A, Qiu JH,Narita Y,et al.High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem,1999,274(48):34450-34458.
    [84]Lu YM, Mansuy IM,Kandel ER, et al.Calcineurin-mediated LTD of GABAergic inhlbition underlies the increased excitability of CA1 neurons associated with LTP. Neuron,2000,26(1):197-205.
    [85]Connolly CN,Kittler JT, Thomas P, et al.Cell surface stability of gamma-aminobutyric acid type A receptors.Dependence on protein kinase C activity and subunit composition.J Biol Chem,1999,274(51):36565-36572.
    [86]Jones MV,Westbrook GL.Shaping of IPSCs by endogenous calcineurin activity. J Neurosci.1997,17(20):7626-7633.
    [87]Maroder M,Bellavia D,Vacca A,et al. The thymus at the crossroad of neuroimmune interactions[J]. Ann N Y Acad Sci.2000,917:741-747.
    [88]李晓林,杨倩倩,刘金之,等.他罗利姆对氯化锂-匹鲁卡品癫痫持续状态炎性因子表达的影响[J].山东大学学报(医学版),2012,50(2):11-15.
    [89]Fabene P F, Navarro Mora G, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy[J]. Nat Med,2008,14(12):1377-1383.
    [90]De Laurentiis A, Pisera D, Lasaga M, et al. Effect of interleukin-6 and tumor necrosis factor-alpha on GABA release from mediobasal hypothalamus and posterior pituitary[J]. Neuroimmunomdulation,2000,7(2):77-83.
    [91]Vezzani A, Moneta D, Richichi C, et al. Functional role of inflammatory cytokines and anti-inflammatory molecules in seizures and epileptogenesis[J]. Epilepsa,2002,43(Suppl 5):30-35.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700